Walleye Capital
WVE icon

Walleye Capital’s Wave Life Sciences WVE Stock Holding History

Walleye Capital’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.58M Buy
493,512
+114,689
+30% +$1.49M 0.01% 1024
2025
Q4 		$6.44M Sell
378,823
-351,816
-48% -$3.57M 0.02% 956
2025
Q3 		$5.35M Buy
730,639
+262,752
+56% +$2.13M 0.02% 887
2025
Q2 		$3.04M Buy
467,887
+77,047
+20% +$509K 0.01% 1200
2025
Q1 		$3.16M Sell
390,840
-135,858
-26% -$1.49M 0.01% 1095
2024
Q4 		$6.52M Sell
526,698
-75,743
-13% -$1.01M 0.02% 906
2024
Q3 		$4.94M Buy
+602,441
New +$3.6M 0.01% 1178
2024
Q2 		– Sell
-55,129
Closed -$340K – 6066
2024
Q1 		$340K Sell
55,129
-377,804
-87% -$1.89M ﹤0.01% 3537
2023
Q4 		$2.19M Buy
432,933
+283,973
+191% +$1.52M ﹤0.01% 1711
2023
Q3 		$857K Buy
+148,960
New +$680K ﹤0.01% 2376
2023
Q1 		– Sell
-86,026
Closed -$602K – 4423
2022
Q4 		$602K Sell
86,026
-315,474
-79% -$1.45M 0.01% 1337
2022
Q3 		$1.45M Buy
+401,500
New +$1.33M 0.03% 726
2022
Q1 		– Sell
-25,023
Closed -$79K – 2631
2021
Q4 		$79K Buy
+25,023
New +$104K ﹤0.01% 1729
2021
Q1 		– Sell
-155,806
Closed -$1.23K – 1371
2020
Q4 		$1.23K Sell
155,806
-41,300
-21% -$347K 0.08% 232
2020
Q3 		$1.67M Buy
+197,106
New +$2.16M 0.19% 144

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Walleye Capital's WVE Position: Q1 2026 in Review

Walleye Capital increased its Wave Life Sciences (WVE) stake by 30% in Q1 2026, buying an estimated $1.49M and bringing the position to 493,512 shares worth $3.58M. The position accounts for 0.01% of the portfolio, ranked #1024.

Walleye Capital first reported a position in WVE in Q3 2020 and has held it in 15 quarters since. The position peaked at $6.52M in Q4 2024. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Walleye Capital held 493,512 shares of Wave Life Sciences worth $3.58M as of Q1 2026.
  • Walleye Capital bought 114,689 Wave Life Sciences shares in Q1 2026, an estimated $1.49M.
  • Wave Life Sciences made up 0.01% of Walleye Capital's portfolio in Q1 2026, its #1024 holding.
  • Walleye Capital first reported a position in Wave Life Sciences in Q3 2020 and has held it in 15 quarters since.
  • Walleye Capital's Wave Life Sciences position peaked at $6.52M in Q4 2024.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.